News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,011 Results
Type
Article (42691)
Company Profile (439)
Press Release (677880)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (208883)
Career Advice (2025)
Deals (36047)
Drug Delivery (104)
Drug Development (83692)
Employer Resources (173)
FDA (16511)
Job Trends (15130)
News (353174)
Policy (33154)
Tag
Academia (2645)
Accelerated approval (12)
Adcomms (26)
Allergies (98)
Alliances (51105)
ALS (114)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (168)
Approvals (16492)
Artificial intelligence (331)
Autoimmune disease (33)
Automation (19)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (36)
Breast cancer (375)
Cancer (2959)
Cardiovascular disease (227)
Career advice (1694)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (527)
Cervical cancer (22)
Clinical research (68686)
Collaboration (1067)
Company closure (3)
Compensation (699)
Complete response letters (28)
COVID-19 (2685)
CRISPR (64)
C-suite (343)
Cystic fibrosis (118)
Data (3053)
Decentralized trials (2)
Denatured (31)
Depression (71)
Diabetes (351)
Diagnostics (6484)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (130)
Drug shortages (29)
Duchenne muscular dystrophy (133)
Earnings (88713)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117375)
Executive appointments (873)
FDA (18193)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (976)
Gene editing (141)
Generative AI (23)
Gene therapy (406)
GLP-1 (826)
Government (4593)
Grass and pollen (4)
Guidances (181)
Healthcare (19172)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (9)
Indications (40)
Infectious disease (2861)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (122)
Interviews (312)
IPO (16875)
IRA (47)
Job creations (3708)
Job search strategy (1436)
Kidney cancer (13)
Labor market (52)
Layoffs (525)
Leadership (19)
Legal (8006)
Liver cancer (80)
Longevity (11)
Lung cancer (414)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (399)
MASH (94)
Medical device (13616)
Medtech (13621)
Mergers & acquisitions (19893)
Metabolic disorders (887)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (129)
Neuropsychiatric disorders (39)
Neuroscience (2219)
NextGen: Class of 2025 (6759)
Non-profit (4558)
Now hiring (47)
Obesity (452)
Opinion (237)
Ovarian cancer (103)
Pain (112)
Pancreatic cancer (121)
Parkinson's disease (193)
Partnered (22)
Patents (303)
Patient recruitment (170)
Peanut (51)
People (59095)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21588)
Phase II (30312)
Phase III (22389)
Pipeline (1665)
Policy (212)
Postmarket research (2601)
Preclinical (9274)
Press Release (67)
Prostate cancer (146)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (490)
Real estate (6025)
Recruiting (67)
Regulatory (23117)
Reports (50)
Research institute (2422)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3776)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (58)
Vaccines (802)
Venture capital (56)
Weight loss (278)
Women's health (49)
Worklife (17)
Date
Today (97)
Last 7 days (378)
Last 30 days (1881)
Last 365 days (32020)
2025 (17292)
2024 (36303)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (738)
Alabama (67)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39655)
Australia (6580)
California (7605)
Canada (2378)
China (695)
Colorado (328)
Connecticut (333)
Delaware (195)
Europe (86726)
Florida (1126)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (660)
India (27)
Indiana (365)
Iowa (18)
Japan (232)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1045)
Massachusetts (5748)
Michigan (248)
Minnesota (459)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2123)
New Mexico (30)
New York (2118)
North Carolina (1150)
North Dakota (9)
Northern California (3321)
Ohio (239)
Oklahoma (16)
Oregon (38)
Pennsylvania (1631)
Puerto Rico (17)
Rhode Island (37)
South America (1112)
South Carolina (34)
South Dakota (1)
Southern California (2835)
Tennessee (126)
Texas (1149)
United States (28290)
Utah (223)
Virginia (192)
Washington D.C. (74)
Washington State (658)
West Virginia (4)
Wisconsin (70)
721,011 Results for "vistagen therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vistagen Appoints Elissa Cote as Chief Corporate Development Officer
June 25, 2025
·
7 min read
Press Releases
Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
June 17, 2025
·
13 min read
Press Releases
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
May 23, 2025
·
2 min read
Press Releases
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
May 28, 2025
·
1 min read
Press Releases
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
June 13, 2025
·
2 min read
Press Releases
Vistagen to Present at the 2025 Anxiety and Depression Association Conference
March 19, 2025
·
4 min read
Press Releases
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
June 2, 2025
·
8 min read
Press Releases
Vistagen to Participate in Stifel 2025 Virtual CNS Forum
March 4, 2025
·
1 min read
Press Releases
Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference
April 17, 2025
·
7 min read
Press Releases
Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
February 20, 2025
·
1 min read
1 of 72,102
Next
